Trial site
Mount Sinai Hospital Medical Center
- 21running trials
- 7closed trials
The trials here
What the 29 trials at this site are about, from their registry records.
- Conditions
- Lung cancer10 trials
- Colorectal cancer5 trials
- Metastatic breast cancer5 trials
- Multiple myeloma5 trials
- Ovarian cancer5 trials
- Triple-negative breast cancer4 trials
- Bladder cancer3 trials
- Gastric and oesophageal cancer3 trials
- Pancreatic cancer3 trials
- Prostate cancer3 trials
- Acute lymphoblastic leukaemia2 trials
- Childhood cancers2 trials
- and 15 more
- Phase
- Phase 319 trials
- Phase 26 trials
- Phase 2/32 trials
- Status
- Active, not recruiting13 trials
- Recruiting8 trials
- Completed7 trials
- Suspended1 trial
- Lead sponsor
- National Cancer Institute (NCI)17 trials
- Alliance for Clinical Trials in Oncology3 trials
- ECOG-ACRIN Cancer Research Group3 trials
- SWOG Cancer Research Network3 trials
- NRG Oncology2 trials
- and 1 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Recruiting
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Active, not recruiting
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Active, not recruiting
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Ovarian cancer3 recruiting
- Childhood cancers2 recruiting
- Colorectal cancer2 recruiting
- Gastric and oesophageal cancer2 recruiting
- Lung cancer2 recruiting
- Metastatic breast cancer2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Acute myeloid leukaemia1 recruiting
- Bladder cancer1 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Chronic myeloid leukaemia1 recruiting
- Endometrial cancer1 recruiting
- Kidney cancer1 recruiting
- Melanoma1 recruiting
- Multiple myeloma1 recruiting
- Pancreatic cancer1 recruiting
- Prostate cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Completed
Completed
Completed
S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026